Radius Health downgraded by Morgan Stanley with a new price target

12/10/21 7:33:03 AM ET

Industrial Specialties

Consumer Discretionary

Morgan Stanley downgraded Radius Health from Equal-Weight to Underweight and set a new price target of $7.00 from $18.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RDUS

Date	Price Target	Rating	Analyst
12/2/2024	$22.00	Neutral	Goldman
5/30/2024		Sell → Neutral	Seaport Research Partners
2/28/2024	$17.50	Neutral → Sell	Seaport Research Partners
12/14/2023		Neutral	Seaport Research Partners
6/8/2022	$8.00	Underperform → Neutral	BofA Securities
5/23/2022	$7.00	Mkt Perform	SVB Leerink
12/10/2021	$18.00 → $7.00	Equal-Weight → Underweight	Morgan Stanley
12/10/2021	$33.00 → $12.00	Buy → Neutral	Goldman Sachs